Literature DB >> 29566282

Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling.

Ying Xu1, Bing Shu2, Ye Tian3, Guangxi Wang4, Yongjun Wang2, Jinwu Wang5, Yufeng Dong2,4.   

Abstract

Oleanolic acid (OA), a naturally occurring triterpenoid, exhibits potential antitumor activity in several tumor cell lines. Although the inhibition effects of OA on proliferation and survival in human cancers have been confirmed, the potential mechanism underlying OA-induced osteosarcoma cell death has not yet been fully elucidated. Our results in this study showed that OA inhibits proliferation and viability of osteosarcoma cells in a dose-dependent manner. Flow cytometry assays revealed that apoptosis in osteosarcoma cells was significantly induced by OA treatment, while this induction was blocked by Jagged1-mediated activation of Notch signaling. Western blot analysis and a mitochondrial membrane potential assay demonstrated that OA functions through the mitochondrial apoptosis pathway. More importantly, our data revealed that OA treatment interrupted the balance between pro-apoptotic factors and anti-apoptotic factors in osteosarcoma cells by inhibition of the Notch signaling pathway. These data suggest that OA induces osteosarcoma cell apoptosis by targeting mitochondria in a Notch signaling-dependent manner. Thus, OA may be a promising drug for adjuvant chemotherapy in osteosarcoma.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Notch signaling; cell apoptosis; oleanolic acid; osteosarcoma

Mesh:

Substances:

Year:  2018        PMID: 29566282     DOI: 10.1002/mc.22810

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

Review 1.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

Review 2.  Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I).

Authors:  Marius Mioc; Andreea Milan; Daniel Malița; Alexandra Mioc; Alexandra Prodea; Roxana Racoviceanu; Roxana Ghiulai; Andreea Cristea; Florina Căruntu; Codruța Șoica
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

Review 3.  A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.

Authors:  Muhammad Naeem; Muhammad Omer Iqbal; Humaira Khan; Muhammad Masood Ahmed; Muhammad Farooq; Muhammad Moeen Aadil; Mohamad Ikhwan Jamaludin; Abu Hazafa; Wan-Chi Tsai
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

4.  Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20.

Authors:  Yuan Gao; Lunhao Bai; Guanning Shang
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

5.  Decrease of ABCB1 protein expression and increase of G1 phase arrest induced by oleanolic acid in human multidrug-resistant cancer cells.

Authors:  Didi Wang; Jincai Wang; Juan Zhang; Xin Yi; Jinhua Piao; Li Li; Jianjie Wang; Pengxia Zhang; Qiyang He
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

Review 6.  Systematic Review of Potential Anticancerous Activities of Erythrina senegalensis DC (Fabaceae).

Authors:  Souleymane Fofana; Moussa Ouédraogo; Rafaèle Calvo Esposito; Windbedema Prisca Ouedraogo; Cédric Delporte; Pierre Van Antwerpen; Véronique Mathieu; Innocent Pierre Guissou
Journal:  Plants (Basel)       Date:  2021-12-22

Review 7.  Onco-Preventive and Chemo-Protective Effects of Apple Bioactive Compounds.

Authors:  Linda Nezbedova; Tony McGhie; Mark Christensen; Julian Heyes; Noha Ahmed Nasef; Sunali Mehta
Journal:  Nutrients       Date:  2021-11-11       Impact factor: 5.717

Review 8.  The roles of glycolysis in osteosarcoma.

Authors:  Zuxi Feng; Yanghuan Ou; Liang Hao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.